Global University Venturing

Genetic testing company Prenetics leveraged a UK-based subsidiary to buy Oxsed having piloted the latter's rapid coronavirus screening system.

Intel is set to buy Stanford University-backed machine learning optimisation business SigOpt, which had raised at least $8.6m in funding.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The angel investment firm, which focuses on University of Oxford-linked businesses, has raised an undisclosed amount towards the $5m target for its second fund.

University of Colorado and Osage University Partners both backed a round that took the immune regulation-focused university spinout's total funding to at least $106m.

Propel Dayton is a three-phase accelerator targeting pre-spinout concepts leveraging University of Dayton's intellectual property.

4100 Group led an extension to the Stanford-StartX Fund-backed healthcare AI technology provider's latest round, which now stands at $30m.

The fitness and sleep tracker provider, an alumnus of Harvard Innovation Lab, was valued at $1.2bn in a round that took its total funding past $200m.

Spun out of University of Louisville, Koligo Therapeutics has already launched its first cell therapy product and aims to commercialise a treatment for covid-19.

University of Utah's newly launched software-focused accelerator is backed by an early-stage fund of undisclosed size.

Novartis has bought Vedere Bio, a retinal disease therapy spinout of UC Berkeley also exploiting UPenn research, to expand its gene medicine capabilities.